SFA THERAPEUTICS
Live / Registered — Registered (as of 12 Sept 2023)
What this means for you
Registered since 12 Sept 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Sept 2029: the §8 declaration of use).
Record
- Serial number
- 97348334
- Registration number
- 7165936
- Mark type
- Word mark
- Filed
- 05 Apr 2022
- Published for opposition
- 28 Feb 2023
- Registered
- 12 Sept 2023
- Next maintenance filing
- §8 declaration of use, due by 12 Sept 2029 (grace period to 12 Mar 2030)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; pharmaceutical products for the treatment and prevention of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the fields of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; research and development of pharmaceuticals for the treatment of chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, cancer, and ophthalmic diseases; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials
Owner
- SFA Therapeutics, Inc., Jenkintown, PA, US
- SFA Therapeutics, Inc., Jenkintown, PA, US
- SFA Therapeutics, Inc., Jenkintown, PA, US
Prosecution history
- 10 Nov 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 10 Nov 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 12 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jun 2023 — USE AMENDMENT FILED
- 22 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Jun 2023 — TEAS STATEMENT OF USE RECEIVED
- 25 Apr 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Feb 2023 — PUBLISHED FOR OPPOSITION
- 08 Feb 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jan 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER